Clinical Trial Update: Allopregnanolone (Zuranolone) in Post-stroke Depression [Phase 2]

View source ↗

Summary

Phase 2 trial of Allopregnanolone (Zuranolone) for post-stroke depression is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Depression

Drugs mentioned

• Zuranolone (zuranolone)

Snippet

Sponsor: Duke University | Conditions: Post Stroke Depression | Phase 2 | Status: RECRUITING